CD34 and ischemia: Taken together, records from preclinical studies propose that CD34+ cells differentiate into ECs, integrate into vascular system, and secrete angiogenic factors, promoting vascular regeneration in the microcirculation and improving myocardial perfusion in ischemia-induced tissue damage.